Premium
Developed countries should use inactivated polio vaccine for the prevention of poliomyelitis
Author(s) -
Plotkin Stanley A.
Publication year - 1997
Publication title -
reviews in medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.06
H-Index - 90
eISSN - 1099-1654
pISSN - 1052-9276
DOI - 10.1002/(sici)1099-1654(199707)7:2<75::aid-rmv192>3.0.co;2-o
Subject(s) - poliomyelitis , medicine , virology , poliomyelitis eradication , polio vaccine , poliovirus , environmental health , virus
As the public health situation regarding polio changes, we should not be afraid to change our thinking about vaccination policy. OPV is still the vaccine of choice to eradicate wild poliomyelitis from the developing world. However, in developed countries free of poliomyelitis there is no longer a necessity to tolerate VAPP as the consequence of vaccination. IPV as part of combination vaccines or in mixed schedules with OPV is preferable and is in process of becoming the norm for those countries. © 1997 John Wiley & Sons, Ltd.